norfloxacin has been researched along with Abscess in 3 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Abscess: Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pefloxacin (Pef) is a new quinolone which has been shown to have good in-vitro activity against Staphylococcus aureus, and to reach high tissue concentrations." | 5.27 | Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses. ( Bouanchaud, DH; Huet, Y; Rolin, O, 1986) |
| "Ofloxacin, a new pyridone-carboxylic acid derivative, was evaluated in descending nephritis and subcutaneous abscess models with Staphylococcus aureus in mice in comparison with norfloxacin." | 3.67 | Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice. ( Fujimoto, T; Katami, K; Osada, Y; Sato, M; Tachizawa, H; Tsumura, M; Une, T, 1986) |
| "Pefloxacin (Pef) is a new quinolone which has been shown to have good in-vitro activity against Staphylococcus aureus, and to reach high tissue concentrations." | 1.27 | Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses. ( Bouanchaud, DH; Huet, Y; Rolin, O, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghadage, DP | 1 |
| Bal, AM | 1 |
| Rolin, O | 1 |
| Huet, Y | 1 |
| Bouanchaud, DH | 1 |
| Fujimoto, T | 1 |
| Sato, M | 1 |
| Katami, K | 1 |
| Osada, Y | 1 |
| Tsumura, M | 1 |
| Tachizawa, H | 1 |
| Une, T | 1 |
3 other studies available for norfloxacin and Abscess
| Article | Year |
|---|---|
Isolation of Salmonella enterica serotype Worthington from a splenic abscess in a patient with chronic myeloid leukemia.
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Multiple, Bacteria | 2002 |
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injection | 1986 |
Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Autoradiography; Disease Models, Animal; Kinetics; Male; Mi | 1986 |